Career Development Seminar: Dr. Nick Shah

Jun 30, 2020
|
12:00pm–1:00pm
Student Event
Details

Dr. Nick Shah

The MBP Career Development Association is looking forward to hosting MBP Alumni, Dr. Nick Shah, on Tuesday, June 30, 2020 from 12 PM to 1 PM. Dr. Nick Shah is the Head of In Vitro Pharmacology, DiCE Molecules and he will be discussing his career path in drug discovery and commercialization.

Biography

Dr. Nick Shah is a scientist and leader with extensive experience in leading teams that discover novel therapies against difficult drug targets. He currently leads the In Vitro Pharmacology group at DiCE Molecules where the team is working to discover and develop innovative therapies in immunology.

Prior to DiCE, Nick was an early scientist at Flexus Biosciences where the team discovered Linrodostat (BMS-986205) which is in Phase II testing for immuno-oncology. He also worked with the FLX Bio (now RAPT Therapeutics) team to discover FLX475 (Phase I/II for immuno-oncology) and RPT193 (Phase I for atopic dermatitis). Throughout his career, he has been deeply involved in assay development for drug discovery while leading project teams and managing multiple large-scale hit discovery campaigns.
As a volunteer, Nick advises early-stage startup founders through two accelerators: Springboard and Creative Destruction Lab. He also serves as a judge and career panelist for the BioGENEius Challenge, an international competition for high school science students. Nick completed his PhD at the University of Toronto and a postdoctoral fellowship at Stanford University.

Please RSVP using the following link by June 28, 2020 and a Zoom link will emailed to you: https://forms.gle/DTivbb5veJtYFzK86

Location
Delivered Online via Zoom Meeting
2020-06-30 16:00:00 2020-06-30 17:00:00 UTC Career Development Seminar: Dr. Nick Shah The MBP Career Development Association is looking forward to hosting MBP Alumni, Dr. Nick Shah, on Tuesday, June 30, 2020 from 12 PM to 1 PM. Dr. Nick Shah is the Head of In Vitro Pharmacology, DiCE Molecules and he will be discussing his career path in drug discovery and commercialization. Biography Dr. Nick Shah is a scientist and leader with extensive experience in leading teams that discover novel therapies against difficult drug targets. He currently leads the In Vitro Pharmacology group at DiCE Molecules where the team is working to discover and develop innovative therapies in immunology. Prior to DiCE, Nick was an early scientist at Flexus Biosciences where the team discovered Linrodostat (BMS-986205) which is in Phase II testing for immuno-oncology. He also worked with the FLX Bio (now RAPT Therapeutics) team to discover FLX475 (Phase I/II for immuno-oncology) and RPT193 (Phase I for atopic dermatitis). Throughout his career, he has been deeply involved in assay development for drug discovery while leading project teams and managing multiple large-scale hit discovery campaigns.As a volunteer, Nick advises early-stage startup founders through two accelerators: Springboard and Creative Destruction Lab. He also serves as a judge and career panelist for the BioGENEius Challenge, an international competition for high school science students. Nick completed his PhD at the University of Toronto and a postdoctoral fellowship at Stanford University. Please RSVP using the following link by June 28, 2020 and a Zoom link will emailed to you: https://forms.gle/DTivbb5veJtYFzK86 Delivered Online via Zoom Meeting mbpgsa@gmail.com